Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Analysis of DR Progression to Identify Risks and Need for Treatment — Stella

Home/Diabetic Retinopathy/Analysis of DR Progression to Identify Risks and Need for Treatment

View on ClinicalTrials.gov

Recruiting

Back to Diabetic Retinopathy trials

Analysis of DR Progression to Identify Risks and Need for Treatment

Trial locations(1 site)

Portugal

AIBILI-Clinical Trial Centre, Portugal, Coimbra District

Key details

Sponsor

Association for Innovation and Biomedical Research on Light and Image

Collaborators

Fundação para a Ciência e a Tecnologia

Enrollment target

~1,000 participants

Started

November 2025

Primary completion

November 2026

Age range

35 Years – 90 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.